search
Back to results

Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain (MEOPA)

Primary Purpose

Acute Pain

Status
Completed
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Premixed 50% nitrous oxide and oxygen (Kalinox)
medical air
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Pain focused on measuring premixed nitrous oxide and oxygen, acute pain, prehospital setting

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged 18 years old
  • Patients with a moderate acute pain (NRS score between 3 and 6)

Exclusion Criteria:

  • Contraindication of premixed 50% nitrous oxide and oxygen
  • Recent treatment of analgesic (less than 6 hours)

Sites / Locations

  • Universty Hospital Toulouse SAMU 31

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

premixed 50% nitrous oxide and oxygen

medical air

Arm Description

Outcomes

Primary Outcome Measures

Number of patients with pain relief Number of patients with pain relief Number of patients with pain relief
Pain is mesured with a numerical rating scale (NRS)score on 10.Pain relief is defined by a NRS score of 3 or less

Secondary Outcome Measures

Delay of analgesia (e.g. delay required to obtain analgesia)
Analgesia is obtained when the numerical rating scale score is or less than 3/10
Adverse events
Occurrence of any adverse event from a predefined list. Nausea, Emesis, Dizziness, Drowsiness, Dysphoria, Anxiety, Ear pain

Full Information

First Posted
June 22, 2010
Last Updated
May 10, 2017
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT01356745
Brief Title
Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain
Acronym
MEOPA
Official Title
Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain: a Randomized Double-blind Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
February 2010 (undefined)
Primary Completion Date
May 2011 (Actual)
Study Completion Date
May 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Less than 10% of patients with a traumatic pain have been managed by a physician before to be admitted in an emergency service. 50 % of those patients have been carried by paramedics. Premixed nitrous oxide and oxygen is often used by paramedics, but no scientific studies have demonstrated its efficacy. The aim of the study is to demonstrate the efficacy of premixed nitrous oxide and oxygen in patients with out-of-hospital moderate acute pain.
Detailed Description
The study will evaluate the efficacy of premixed nitrous oxide and oxygen (MEOPA) in patients with out-of-hospital moderate acute pain. The primary endpoint is the percentage of patients with pain relief (with a numerical rating scale of 3/10 or lower) 15 minutes after randomisation. Secondary endpoints are treatment safety and adverse events, time to analgesia and duration of analgesia. This study will expect 60 patients assigned in two parallel groups, defined by a randomization scheme. Group assignments were sealed in opaque envelopes and will be open sequentially by the dispatcher when the paramedic is ready to include the patient. The letter contained in the envelope corresponds to the cylinder to use. Eligible patients with a numeric rating scale (NRS) score between 3 and 6/10 are randomly allocated to receive either MEOPA, or medical air. Fifteen minutes after the randomisation, all patients will receive MEOPA from a distinct cylinder. Pain score will be measured at baseline and every 5 minutes until pain relief will be obtained. The paramedic blinded to the analgesic treatment groups will do all assessments of patients. The safety evaluation will include non invasive monitoring of blood pressure, heart rate, oxygen saturation by pulse oximetry (SpO2) and adverse events collection.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Pain
Keywords
premixed nitrous oxide and oxygen, acute pain, prehospital setting

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
premixed 50% nitrous oxide and oxygen
Arm Type
Experimental
Arm Title
medical air
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Premixed 50% nitrous oxide and oxygen (Kalinox)
Intervention Description
15 min inhalation dose (maximum duration of treatment of a subject)
Intervention Type
Drug
Intervention Name(s)
medical air
Intervention Description
inhalation gas for inhalation use
Primary Outcome Measure Information:
Title
Number of patients with pain relief Number of patients with pain relief Number of patients with pain relief
Description
Pain is mesured with a numerical rating scale (NRS)score on 10.Pain relief is defined by a NRS score of 3 or less
Time Frame
15 minutes
Secondary Outcome Measure Information:
Title
Delay of analgesia (e.g. delay required to obtain analgesia)
Description
Analgesia is obtained when the numerical rating scale score is or less than 3/10
Time Frame
Every 5 minutes from randomization for a one hour period
Title
Adverse events
Description
Occurrence of any adverse event from a predefined list. Nausea, Emesis, Dizziness, Drowsiness, Dysphoria, Anxiety, Ear pain
Time Frame
Every 5 minutes from randomization for a one hour period

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 18 years old Patients with a moderate acute pain (NRS score between 3 and 6) Exclusion Criteria: Contraindication of premixed 50% nitrous oxide and oxygen Recent treatment of analgesic (less than 6 hours)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Louis DUCASSE, MD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universty Hospital Toulouse SAMU 31
City
Toulouse
ZIP/Postal Code
31059
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
23406077
Citation
Ducasse JL, Siksik G, Durand-Bechu M, Couarraze S, Valle B, Lecoules N, Marco P, Lacombe T, Bounes V. Nitrous oxide for early analgesia in the emergency setting: a randomized, double-blind multicenter prehospital trial. Acad Emerg Med. 2013 Feb;20(2):178-84. doi: 10.1111/acem.12072.
Results Reference
result

Learn more about this trial

Efficacy of Premixed Nitrous Oxide and Oxygen in Patient With Out-of-hospital Moderate Acute Pain

We'll reach out to this number within 24 hrs